Active Lives, Safer Choices: Exercise & Diabetes with myLoop powered by CamAPS FX
Over 1000 healthcare professionals registered for our recent webinar with Prof. Othmar Moser on Exercise and myLoop powered by CamAPS FX, highlighting the strong interest in this important topic.
The session covered practical strategies for managing physical activity in patients using AID therapy and provided valuable insights to optimize care. Feedback was highly positive, with the majority of participants reporting improved confidence in starting and optimizing myLoop, and over 90% rating the content as valuable or very valuable for their daily practice.Watch the full recording now on-demand and benefit from expert guidance on supporting your patients with exercise management in AID therapy.
Why this matters
Exercise is one of the best tools we have for improving health in people with type 1 diabetes (T1D) — yet fear of hypoglycaemia still keeps many patients and families on the sidelines. This webinar, hosted by Hind Alameddine and presented by Prof. Othmar Moser (University of Graz, Austria), explored how myLoop powered by CamAPS FX helps patients move with confidence.
The challenges patients face
Fear of lows: Parents and adults alike often avoid activity because of hypoglycaemia risk.
Avoiding highs: With today’s CGM visibility, many also worry about hyperglycaemia around workouts.
Perceived loss of control: Some blame exercise for higher HbA1c, when in reality it’s about balancing carbs and insulin.
What the evidence shows
Typical patterns:
Moderate activity → glucose usually drops.
Sprints, resistance training, or fasted exercise → glucose may rise.
Smart insulin management:
Personal glucose target should be increased and "Ease-off" should be started.
Increase delivery when glucose is climbing — possible through "Boost" mode or target adjustments in myLoop powered by CamAPS FX.
Carbohydrate strategy: Replace constant snacking with a clear threshold (e.g. <126 mg/dL / 7 mmol/L) to guide when and how much to consume.
New large-scale insights
Analysis of >420,000 exercise sessions (3,200 people with T1D) revealed:
Hypoglycaemia risk is not highest during exercise — it spikes in the first hour afterwards.
Evening exercise adds an extra risk window at 2–3 am, making nocturnal hypoglycemia a key concern.
Clinical takeaway: For high-risk patients, morning or midday activity is safer than late-evening exercise.
The bottom line
With the right tools, education, and planning, exercise doesn’t have to be feared. myLoop powered by CamAPS FX gives patients the flexibility to adapt insulin delivery, reduce risk, and enjoy the benefits of an active lifestyle.
For HCPs: Encourage patients to set realistic thresholds, adjust insulin around activity, and consider exercise timing to keep glucose in range and confidence high.